Lv1
100 积分 2022-08-12 加入
Safety and activity of CTX130, a CD70-targeted allogeneic CRISPR-Cas9-engineered CAR T-cell therapy, in patients with relapsed or refractory T-cell malignancies (COBALT-LYM): a single-arm, open-label, phase 1, dose-escalation study
15小时前
待确认
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
2天前
已完结
Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results
2天前
已完结
Efficacy and safety of vorolanib plus everolimus in metastatic renal cell carcinoma: A three-arm, randomised, double-blind, multicentre phase III study (CONCEPT)
2个月前
已完结
CD70 is Consistently Expressed in Primary and Metastatic Clear Cell Renal Cell Carcinoma
2个月前
已完结
Hepatitis B Virus Screening and Real Life Data in Patients with Solid Tumor Receiving Chemotherapy
4个月前
已完结
Risk of hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients with undetectable serum HBV DNA after treatment with rituximab for lymphoma: a meta-analysis
4个月前
已完结
Overexpression of folate binding protein and mesothelin are associated with uterine serous carcinoma
4个月前
已关闭
Folate Receptor Alpha Is Preferentially Expressed in the Carcinoma Component of Endometrial Carcinosarcomas: A Potential Target for Adjuvant Therapy
4个月前
已完结
Rationale for folate receptor alpha targeted therapy in “high risk” endometrial carcinomas
4个月前
已完结
皖公网安备34019202002308
